Biolume’s Bioluminescent Imaging (BLI) represents a new method of molecular imaging (non-invasive visualization of cellular processes inside living organisms). By attaching our bioluminescent enzymes to antigens or antibodies, researches are able to monitor disease progression and/or track the efficacy of a drug therapy. Doctors are able to use BLI to light up tumors or illuminate ducts during surgery. Bioluminescent Imaging will allow researchers, doctors, and many others, to see objectives and critical processes with their naked eye, helping them be more efficient and accurate without the need for cumbersome and complicated equipment and procedures.